Sally Wang Liang | Harvard Innovation Labs
Skip to content

Sally Wang Liang

VP of Business Development, Head of Global Business Unit, PepLib

Industry Expert

Sally Wang Liang
Sally Wang Liang is VP of Business Development at PepLib, where she is the head of the Global Business Unit based in Boston, USA. Sally is a life sciences business executive and a multidisciplinary IP & Regulatory lawyer with 15+ years of industry experience. She serves on the Scientific Advisory Board of New Equilibrium Biosciences, an AI Drug Discovery company focused on Intrinsically Disordered Proteins (IDPs). She advised many of the world‚¬„¢s largest pharmaceutical companies and top biotech firms on business strategy as a management consultant; her clients included Pfizer, Sanofi, Novartis, Roche-Genetech, etc. She has been a serial entrepreneur in healthcare: as the CEO and Co-founder of DocFlight, an international telemedicine company, and as Chief Strategy Officer and EVP of IP and Regulatory of a leading digital therapeutics company, Click Therapeutics. As a lawyer, she practiced pharmaceutical patent litigation and IP licensing at the premier intellectual property firm, Venable-Fitzpatrick. She was also involved in life sciences policy making on the national level at the Food and Drug Administration Office of Policy and the US Senate Health Education Labor Pension Committee Health Office. Sally received a A.B. in Biology with high honors from Harvard College, a J.D. from Harvard Law School, and a M.P.H from Harvard T.H. Chan School of Public Health.
Industries

Biotech & Life Sciences, Digital Health, Healthcare, Personal Health & Wellness

More Experts View All